Lack of Ventral Striatal Response to Positive Stimuli in Depressed Versus Normal Subjects

Department of Psychiatry, Cornell University, Итак, New York, United States
American Journal of Psychiatry (Impact Factor: 12.3). 11/2006; 163(10):1784-90. DOI: 10.1176/appi.ajp.163.10.1784
Source: PubMed


Most of the functional neuroimaging studies of depression have focused primarily on the resting state or responses to negatively valenced stimuli. However, depression consists not only of an accentuation of negative affective processing but of an inability to experience pleasure or positive motivation. The authors tested the hypothesis that depressed subjects would show less activation than healthy comparison subjects, in response to positive stimuli, in ventral striatal regions associated with processing of reward and positive stimuli.
Positive, negative, and neutral words were presented to 10 unmedicated depressed patients and 12 healthy comparison subjects in the context of a 3T functional magnetic resonance imaging (MRI) paradigm. Image processing and analysis were performed using statistical parametric mapping with a mixed-effects model. Significant differences in neural responses were assessed, examining group, condition, and interaction effects of interest within the context of a general linear model.
Relative to comparison subjects, depressed patients demonstrated significantly less bilateral ventral striatal activation to positive stimuli, correlating with decreased interest/pleasure in and performance of activities. They also displayed decreased activation to positive stimuli in a dorsomedial frontal region associated with processing of self-related stimuli. Responses of depressed subjects to negative stimuli were consistent with the growing literature on frontolimbic dysfunction in depression.
This finding 1) supports a pathophysiological model of depression that includes reward/motivational pathway dysfunction, 2) suggests a contributing neural substrate of the inability to experience pleasure or engage in rewarding activities, 3) provides greater specification of abnormalities of basal ganglia function in depression, and 4) may help guide treatment approaches.

Download full-text


Available from: Hong Pan, Aug 07, 2014
  • Source
    • "ence and arousal on 9 - point scales identical to that of the Affective Norms for English Words ( Bradley and Lang , 1999 ) . Two memory metrics were calculated from this questionnaire : 1 ) Recognition performance for each word type was calculated by adjusting hit rate ( p ) with false alarm rate ( fp ) using the formula ( p - fp ) / ( 1 - fp ) ( Epstein et al . , 2006 ) ; and 2 ) Memory bias was calculated by subtracting recognition performance for neutral words from that for negative words and for positive words . One participant from the control group did not complete more than 80% of the valence ratings and two participants did not complete more than 80% of the arousal ratings ; therefore , their "
    [Show abstract] [Hide abstract]
    ABSTRACT: This work investigated the impact of heavy marijuana use during adolescence on emotional functioning, as well as the brain functional mediators of this effect. Participants (n = 40) were recruited from the Michigan Longitudinal Study (MLS). Data on marijuana use were collected prospectively beginning in childhood as part of the MLS. Participants were classified as heavy marijuana users (n = 20) or controls with minimal marijuana use. Two facets of emotional functioning—negative emotionality and resiliency (a self-regulatory mechanism)—were assessed as part of the MLS at three time points: mean age 13.4; mean age 19.6; and mean age 23.1. Functional neuroimaging data during an emotion-arousal word task were collected at mean age 20.2. Negative emotionality decreased and resiliency increased across the three time points in controls but not heavy marijuana users. Compared with controls, heavy marijuana users had less activation to negative words in temporal, prefrontal, and occipital cortices, insula, and amygdala. Activation of dorsolateral prefrontal cortex to negative words mediated an association between marijuana group and later negative emotionality. Activation of the cuneus/lingual gyrus mediated an association between marijuana group and later resiliency. Results support growing evidence that heavy marijuana use during adolescence affects later emotional outcomes.
    Full-text · Article · Dec 2015 · Developmental Cognitive Neuroscience
  • Source
    • "A growing awareness of the role of mesolimbic dopamine (DA) in pain perception, specifically in anti-nociception, has emerged in recent years (Hagelberg et al., 2004; Jarcho et al., 2012; Wood, 2008). Although its precise function in nociceptive processes is only partially understood, DA regulation has been shown to be disrupted in MDD and chronic pain (Epstein et al., 2006; Wood, 2008). Several Positron Emission Tomography (PET)-studies demonstrated altered post-synaptic striatal DA neurotransmission in chronic neuropathic pain syndromes including burning mouth, and atypical facial pain, (Hagelberg et al., 2003a, 2003b; Wood et al., 2007b) while an alteration of presynaptic DA transmission was evidenced in FMS (Wood et al., 2007a). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dopamine D2/D3 receptor availability at rest and its association with individual pain perception was investigated using the [(11)C] raclopride PET-method in 24 female Fibromyalgia (FMS) participants with (FMS+, N=11) and without (FMS-, N=13) comorbid depression and in 17 healthy women. Thermal pain thresholds (TPT) and pain responses were assessed outside the scanner. We compared the discriminative capacity, i.e. the individual׳s capacity to discriminate between lower and higher pain intensities and the response criterion, i.e. the subject׳s tendency to report pain during noxious stimulation due to psychological factors. [(11)C] raclopride binding potential (BP), defined as the ratio of specifically bound non-displaceable radioligand at equilibrium (BPND) was used as measure of D2/D3 receptor availability. We found significant group effects of BPND in striatal regions (left ventral striatum, left caudate nucleus and left nucleus accumbens) between FMS+ and FMS- compared to healthy subjects. Correlational analysis showed negative associations between TPT and D2/D3 receptor availability in the left caudate nucleus in FMS-, between TPT and D2/D3 receptor availability in the right caudate nucleus in FMS + and positive associations between TPT and D2/D3 receptor availability in the left putamen and right caudate nucleus in healthy controls. The response criterion was positively associated with D2/D3 receptor availability in the right nucleus accumbens in FMS - and negatively with D2/D3 receptor availability in the left caudate nucleus in healthy controls. Finally, no significant associations between D2/D3 receptor availability and discriminative capacity in any of the groups or regions were determined. These findings provide further support for a disruption of dopaminergic neurotransmission in FMS and implicate DA as important neurochemical moderator of differences in pain perception in FMS patients with and without co-morbid depression.
    Full-text · Article · Dec 2015 · European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology
    • "The assessment of anhedonia is based on subjectively experienced symptoms reported to the physician (e.g. as in the Snaith-Hamilton-Pleasure-Scale SHAPS) [5]. Anhedonia correlates with reduced ventral striatal activation [6] and may be of hypodopaminergic nature due to degenerating dopaminergic mesolimbic projections in PD. Despite being merely a core symptom of depression, anhedonia and apathy may be specific neuropsychiatric symptoms with different neural substrates, independent of depression in PD [7]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Olfactory dysfunction and neuropsychological symptoms like depression and anhedonia are common non-motor symptoms in Parkinson's disease (PD). The assessment of both functional domains includes clinical examination, olfactory testing, and standardized questionnaires. While olfaction is readily assessed by functional tests, the distinction of anhedonia as a separate symptom from other depressive symptoms is challenging. Thus, a test focusing on the assessment of hedonic olfaction may be helpful in the assessment of neuropsychological symptoms in PD. Methods: We examined anhedonia by evaluating the perception of pleasantness of odors in PD patients (n = 57) and healthy controls (n = 46). Pleasantness of odors was registered on a visual 9-point scale. For the assessment of anhedonia we used the Snaith-Hamilton-Pleasure-Scale (SHAPS). Depression was evaluated with the Zung Self-Rating Depression Scale and the Beck Depression Inventory II. Results: PD patients showed a substantial reduction in hedonic olfaction compared to controls (hedonic score: 1.5 vs. 2.2). Hyposmia, one of the most prevalent non-motor symptoms in PD, was a confounding factor. However, even normosmic PD patients showed a reduced hedonic olfaction compared to controls (hedonic score: 1.6 vs. 2.2). Furthermore, we observed a correlation between hedonic olfaction and the SHAPS-score for PD patients even though positive SHAPS-rating was observed in 9% of PD patients only, while no correlation to depression was present. Conclusion: These findings suggest that reduced hedonic olfaction might be an additional neuropsychological feature, probably giving insights into changes in hedonic tone complementary to hyposmia and depression in PD.
    No preview · Article · Sep 2015 · Parkinsonism & Related Disorders
Show more